We enrich life for generations
The products and services of K+S are crucial for supplying the population in the fields of medicine, pharmaceuticals, food production, agriculture and animal feed. By using our underground caverns, we also contribute to an orderly waste management system.
FREP proceedings: Final examination findings do not sustain material preliminary findings and do not result in adjustments to valuations
The German Financial Reporting Enforcement Panel (FREP - “DPR”) today issued its final examination findings. These do not sustain significant preliminary findings and do not result in adjustments to valuations.
Positive outlook for the rest of the year
In this interview, Dr. Burkhard Lohr, Chairman of the Board of Executive Directors of K+S AG, explains the Company's operating performance in the third quarter of 2021, talks about the 2021 outlook and the new corporate strategy.
Significant increase in earnings – forecast raised
In the third quarter, K+S again increased revenues and operating earnings very significantly year-on-year. The forecast for 2021 was increased again.
Forecast K+S Aktiengesellschaft
- K+S raises operating EBITDA outlook for 2021 again to around EUR 630 million (previously: EUR 500 to 600 million; excluding REKS transaction)
- Balanced free cash flow expected for 2021 (previously: EUR -180 million; excluding REKS transaction)
- Antitrust review of REKS transaction still ongoing
Focus on four business segments
K+S's business is focused on four segments: agriculture, industry, consumers, and communities. The same applies in all segments: The customer is the focus of our activities.
We strive for sustainability, because we acknowledge our responsibility to the people, the environment, the communities, and the economy in the regions in which we operate.